Gri bio (nasdaq: gri) to participate in the virtual investor lunch break series

Live video webcast on wednesday, july 17 th at 12:00 pm et la jolla, ca, july 15, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio,” “we,” “our,” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (nkt) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that it will participate in the virtual investor lunch break series on july 17, 2024 at 12:00 pm et. as part of the event, marc hertz, phd, chief executive officer of gri bio, will provide a corporate overview and business outlook.
GRI Ratings Summary
GRI Quant Ranking